Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation
Thiviya Darmarajan(IMU University), Dinesh Kumar Chellappan(IMU University), Bey Hing Goh(Monash University Malaysia), Sachin Kumar Singh(Lovely Professional University), Kamal Dua(University of Technology Sydney), Lakshmana Prabu Sakthivel(Anna University, Chennai), Monica Gulati(Lovely Professional University), Keshav Raj Paudel(University of Technology Sydney), Hari Prasad Devkota(Kumamoto University), Mayuren Candasamy(Institute for Research and Development), Thiagarajan Madheswaran(IMU University), Brian G. Oliver(University of Technology Sydney), Philip M. Hansbro(University of Technology Sydney), Jestin Chellian, Niraj Kumar Jha(Chandigarh University), Gaurav Gupta(Gyan Vihar University), Piyush Kumar Gupta(INTI International University)
Cited by 19
Related Papers
Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities
|Molecules|2016|467
Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention
|Diabetes & Metabolic Syndrome Clinical Research & Reviews|2018|444
Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae)
|Biomolecules|2020|441
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
|Frontiers in Pharmacology|2019|300
Microbiome effects on immunity, health and disease in the lung
|Clinical & Translational Immunology|2017|282